Jeffrey A. Gelfand

发表

VaxCelerate II: Rapid development of a self-assembling vaccine for Lassa fever

D. Baker, A. D. De Groot, H. S. Warren, 2014, Human vaccines & immunotherapeutics.

Clinical sensitivity and interpretation of PCR and serological COVID‐19 diagnostics for patients presenting to the hospital

Melis N. Anahtar, Julie M. Batten, Lauren L. Ritterhouse, 2020, medRxiv.

Acquired C1 inhibitor deficiency as a result of an autoantibody to the reactive center region of C1 inhibitor.

F. Rosen, J. Gelfand, D. Bing, 1994, Journal of Immunology.